siRNA, Anti-Human ARNTL(CAT#: SIRGT00280WQ)
The product SIRGT00280WQ is a type of small interfering RNA (siRNA) that targets ARNTL gene and regulates the expression of gene. The siRNA interferes with the expression of ARNTL gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.
Specifications | |
---|---|
Scale | 20/50/100/200 nmole |
NCBI RefSeq | NM_001030272.2; NM_001030273.2; NM_001178.5; NM_001297719.1; NM_001297722.1; NM_001297724.1; NM_001351804.1; NM_001351805.1; NM_001351806.1; NM_001351807.1; NM_001351808.1; NM_001351809.1; NM_001351810.1; NM_001351811.1; NM_001351812.1; NM_001351813.1; NM_001351814.1; NM_001351815.1; NM_001351816.1; NM_001351817.1; NM_001351818.1; NM_001351819.1; NM_001351820.1; NM_001351821.1; NM_001351822.1; NM_001351823.1; NM_001351824.1 |
Alternative Names | BMAL1; BMAL1c; JAP3; MOP3; PASD3; TIC; bHLHe5 |
Related Diseases | Rem Sleep Behavior Disorder, Advanced Sleep Phase Syndrome |
Purification | HPLC |